Advance purchase agreement for the reservation and supply of pandemic influenza vaccine
Awarded
The competition has ended and a winner has been selected.
- Qualification deadline
- Nov 13, 2024Expired
- Award
- Delivery 20% and 2 more
Brief
The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines in the event of an influenza pandemic during the contract period. The contract (advance purchase agreement) regards reservation of the supplier’s production capacity and the contract will contain an option for purchase of pandemic influenza vaccine in the event of an influenza pandemic called by the WHO during the contract period. The reserved volume of pandemic vaccine is expected to be 7.6 million doses; however, the number of doses may be reduced by SSI as described in the tender documents. SSI expects that the Agreement cannot be awarded without prior negotiations with potential suppliers due to the specific circumstances related to the nature and the complexity of the Agreement and the legal and financial aspects and the associated risks. In essence, the procedure encompasses a complex advance purchase agreement, and SSI is dependent on further information from potential suppliers in order to establish a complete and adequate set of terms and conditions in accordance with what the market operators are able to meet. This makes it necessary for SSI to be able to negotiate various as-pects of both the tender documents and the tenders received and potentially make various changes to the tender documents. Hence, the procurement will be conducted as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All terms and requirements that are not minimum requirements may be subject to negotiation and may be changed or withdrawn during the tender procedure according to SSI’s decision. Thus, SSI encourages all economic operators who comply with the minimum requirements (stated in the Tender Specification, paragraph 5) to apply for prequalification, even if the economic operator cannot comply with other terms and requirements.
Farmasøytisk engroshandel
Result
- SEQIRUS UK LIMITEDWinner
- 1Number of tenders received
- DKK 1Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Reference is made to the Tender Specifications, Appendix A, section 1.1.
Source
No source found in the documents. Check the weight against the tender documents.
Description
Reference is made to the Tender Specifications, Appendix A, section 1.2.
Source
No source found in the documents. Check the weight against the tender documents.
Description
Reference is made to the Tender Specifications, Appendix A, section 1.3.
Source
No source found in the documents. Check the weight against the tender documents.
Description
Reference is made to the Tender Specifications, Appendix A, section 1.4.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Statens Serum Institut
From the notice
The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines in the event of an influenza pandemic during the contract period. The contract (advance purchase agreement) regards reservation of the supplier’s production capacity and the contract will contain an option for purchase of pandemic influenza vaccine in the event of an influenza pandemic called by the WHO during the contract period. The reserved volume of pandemic vaccine is expected to be 7.6 million doses; however, the number of doses may be reduced by SSI as described in the tender documents. SSI expects that the Agreement cannot be awarded without prior negotiations with potential suppliers due to the specific circumstances related to the nature and the complexity of the Agreement and the legal and financial aspects and the associated risks. In essence, the procedure encompasses a complex advance purchase agreement, and SSI is dependent on further information from potential suppliers in order to establish a complete and adequate set of terms and conditions in accordance with what the market operators are able to meet. This makes it necessary for SSI to be able to negotiate various as-pects of both the tender documents and the tenders received and potentially make various changes to the tender documents. Hence, the procurement will be conducted as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All terms and requirements that are not minimum requirements may be subject to negotiation and may be changed or withdrawn during the tender procedure according to SSI’s decision. Thus, SSI encourages all economic operators who comply with the minimum requirements (stated in the Tender Specification, paragraph 5) to apply for prequalification, even if the economic operator cannot comply with other terms and requirements.Main features of the procedureAfter receipt of Indicative Offers (INDO1), SSI will conduct individual negotiation meetings with all tenderers who have submitted an INDO within the deadline stated. The negotiations will be conducted in accordance with the principle of equal treatment, and all tenderers will be given the same amount of time for negotiations with SSI. After the negotiations, SSI may choose to issue revised tender documents for further Indicative Offers or Best and Final Offer (BAFO). The tenderers will be informed thereof at the same time with an invitation to submit an INDO or BAFO. SSI will not pay a participation fee to the tenderers. For further information on the process of the negotiations, reference is made to the tender specifications, paragraph 11.
Contact
nea@ssi.dk- Result · PrequalificationType
- Byen KøbenhavnLocation
- 33651600Main codeVaccines